A Study of Nifecardia SRFC and Adalat OROS in the Treatment of Patients With Essential Hypertension
NCT00173667
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
Nifedipine 30 mg GITS
Sponsor
National Taiwan University Hospital